氨酸脱氨酶解决复制性压力,并保护胰腺癌免受DNA向药物的侵害
Audrey Lumeau1, Nicolas Bery1, Audrey Francès1
1Centre de Recherches en Cancérologie de Toulouse, CRCT, Université de Toulouse, Inserm, CNRS, Toulouse, France.
Cancer research
|January 31, 2024
概括
胰腺癌中丁脱氨酶 (CDA) 的过度表达减少了复制应激,促进了瘤生长和化学抵抗. 向CDA通过增加复制压力来提高对破坏DNA的药物的敏感性.
科学领域:
- 分子生物学分子生物学
- 癌症生物学 癌症生物学
- 生物化学 生物化学
背景情况:
- 氨酸脱氨酶 (CDA) 对于皮里米丁救援途径至关重要,支持DNA和RNA合成.
- 在癌细胞中,CDA 赋予了对脱氧化丁基化疗的耐药性.
- 在胰腺腺癌中,CDA过度表达,与瘤进展相关.
研究的目的:
- 研究CDA在胰腺腺癌中的作用.
- 阐明CDA影响DNA复制和压力的机制.
- 评估CDA作为胰腺癌的治疗点.
主要方法:
- 在患者衍生的胰腺腺癌样本中分析CDA表达.
- 在复制分叉中对CDA本地化和功能进行机制研究.
- 在体外和体内实验涉及CDA沉默在胰腺癌模型中的实验.
- 对复制应激和对DNA破坏性物质 (例如,氧化) 的敏感性进行评估.
主要成果:
- 在胰腺腺癌中,CDA过度表达,对瘤生长至关重要.
- CDA局部化到复制叉,增强复制速度和稳定性,同时减少压力.
- 高CDA表达与对DNA损伤剂的耐药性相关.
- 沉默CDA会增加复制压力,并使胰腺癌细胞对酸敏感.
结论:
- 在胰腺腺癌中,CDA在调节复制应激方面发挥着重要作用.
- CDA表达可能预测治疗疗效.
- 向CDA,特别是与DNA向疗法相结合,可以在癌细胞中诱导不可容忍的复制压力,提供一种潜在的治疗策略.
相关概念视频
DNA Damage can Stall the Cell Cycle
9.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
Restarting Stalled Replication Forks
5.8K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.8K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
The DNA Replication Fork
36.0K
An organism’s genome needs to be duplicated in an efficient and error-free manner for its growth and survival. The replication fork is a Y-shaped active region where two strands of DNA are separated and replicated continuously. The coupling of DNA unzipping and complementary strand synthesis is a characteristic feature of a replication fork. Organisms with small circular DNA, such as E. coli, often have a single origin of replication; therefore, they have only two replication...
36.0K
Overview of DNA Repair
31.0K
In order to be passed through generations, genomic DNA must be undamaged and error-free. However, every day, DNA in a cell undergoes several thousand to a million damaging events by natural causes and external factors. Ionizing radiation such as UV rays, free radicals produced during cellular respiration, and hydrolytic damage from metabolic reactions can alter the structure of DNA. Damages caused include single-base alteration, base dimerization, chain breaks, and cross-linkage.
Chemically...
Chemically...
31.0K


